Image Courtesy : www.facebook.com/iiscbangalore

Scientists at the Indian Institute of Science (IISc) have achieved a significant milestone in the ongoing battle against cancer with their groundbreaking research on hybrid nanoparticles. These innovative nanoparticles, composed of gold and copper sulfide, offer a multifaceted approach to cancer detection and treatment.

The IISc's research aligns with the critical importance of early cancer detection and treatment. Their pioneering work combines both aspects into a single, versatile solution.

According to the official statement, the core of this breakthrough lies in creating hybrid nanoparticles, seamlessly integrating gold and copper sulfide. These nanoparticles possess exceptional properties that empower them to detect and combat cancer cells effectively. When exposed to light, these nanoparticles exhibit a unique property: they absorb the light and convert it into localized heat. This controlled heat application can be precisely directed to cancer cells, offering a targeted therapy approach. Additionally, these nanoparticles produce singlet oxygen atoms, known for their cancer cell toxicity, further enhancing their therapeutic potential.

Beyond their therapeutic capabilities, these hybrid nanoparticles introduce a novel method for cancer detection. They possess a distinctive photoacoustic property, emitting ultrasound waves when illuminated with light. This property enables highly accurate cancer cell detection. Compared to conventional imaging methods like CT and MRI scans, this approach offers superior contrast and resolution.

The potential clinical applications of these hybrid nanoparticles in cancer diagnosis and treatment are immense. They can be activated using light during endoscopic cancer screenings, providing a minimally invasive and precisely targeted approach. Their small size, less than 8 nm, allows them to navigate tissues efficiently and reach tumor sites.

While the nanoparticles' small size suggests potential for natural elimination from the body, comprehensive safety evaluations are imperative before human use. Preliminary tests involving lung cancer and cervical cancer cell lines in laboratory settings have yielded promising results, paving the way for further clinical development.

In summary, the Indian Institute of Science's pioneering research on hybrid nanoparticles marks a significant stride in the fight against cancer. Their unique combination of detection and treatment capabilities showcases their potential to revolutionize cancer care. This innovative approach underscores the pivotal roles of early detection and cutting-edge solutions in the ongoing battle against cancer.

News Source: NDTV